SCHEMBL19089434

SCHEMBL19089434

Fc1c(Cl)cccc1NI

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 1/20 0.40
GRM4 Q14833 1/20 0.40
EGFR P00533 1/20 0.36
SLC40A1 Q9NP59 1/20 0.36
ARNT P27540 1/20 0.35
EPAS1 Q99814 1/20 0.35
TSHR P16473 3/20 0.35
CCR2 P41597 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2A6 P11509 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33
CSNK2A1 P68400 1/20 0.33
IDO1 P14902 1/20 0.33
KAT2B Q92831 1/20 0.33
RIPK1 Q13546 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8311149 0.77 PTGES2 (0.40) PTGES2GRM4EGFRSLC40A1ARNT
SCHEMBL897552 0.77 PTGES2 (0.44) PTGES2GRM4EGFRSLC40A1ARNT
SCHEMBL21279548 0.76 CES2 (0.38) PTGES2EGFRMEN1KMT2ACSNK2A1
Hydrochloric Acid SCHEMBL31597662 0.76 PTGES2 (0.42) PTGES2GRM4EGFRSLC40A1ARNT
Hydrochloric Acid SCHEMBL670310 0.76 PTGES2 (0.42) PTGES2GRM4EGFRSLC40A1ARNT
SCHEMBL17948090 0.76 PTGES2 (0.39) PTGES2GRM4EGFRSLC40A1ARNT
SCHEMBL320817 0.74
SCHEMBL21937459 0.73
SCHEMBL22131081 0.72 MEN1 (0.41) PTGES2GRM4SLC40A1CCR2MEN1
SCHEMBL22131082 0.72 ALDH1A1 (0.38) PTGES2GRM4CCR2CYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312160-B1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS INC (US) 2020-03-18 EP disclosed
WO-2017114500-A1 ACRYLANILIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF IN PHARMACY 恩瑞生物医药科技(上海)有限公司 2017-07-06 WO disclosed